Molecular Pharmaceutics
[ASAP] Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of <italic toggle=”yes”>P</italic>‑Glycoprotein
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00889
Molecular Pharmaceutics
[ASAP] Acalabrutinib Maleate Tablets: The Physiologically Based Biopharmaceutics Model behind the Drug Product Dissolution Specification
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00005
Molecular Pharmaceutics
[ASAP] Two-Chain Mature Hepatocyte Growth Factor-Specific Positron Emission Tomography Imaging in Tumors Using <sup>64</sup>Cu-Labeled HiP-8, a Nonstandard Macrocyclic Peptide Probe
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01020
Molecular Pharmaceutics
[ASAP] Water Sorption in Rubbery and Glassy Polymers, Nifedipine, and Their ASDs
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00006
Molecular Pharmaceutics
[ASAP] Self-Assembled Redox-Sensitive Polymeric Nanostructures Facilitate the Intracellular Delivery of Paclitaxel for Improved Breast Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00673
Molecular Pharmaceutics
[ASAP] An Engineered Design of Self-Assembly Nanomedicine Guided by Molecular Dynamic Simulation for Photodynamic and Hypoxia-Directed Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01079
Molecular Pharmaceutics
[ASAP] Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV‑1 Latent Reservoir Cell Types
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01030
Molecular Pharmaceutics
[ASAP] Noninvasive Positron Emission Tomography Imaging of SIRT1 in a Model of Early-Stage Alcoholic Liver Disease
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00904
Molecular Pharmaceutics
[ASAP] <named-content content-type=”genus-species” xlink:type=”simple”>Bletilla striata</named-content> Polysaccharide Nanoparticles Improved the Therapeutic Efficacy of Omeprazole on the Rat Gastric Ulcer Induced by Ethanol
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00922
Molecular Pharmaceutics
[ASAP] Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00897